Glucose Paracélsia

Glucose Paracélsia is an intravenous solution that contains glucose as its sole active ingredient. The product is supplied in a sterile liquid form for parenteral administration, with the specific concentration not disclosed publicly. It is marketed in the European Union and is available by prescription only. As an excipient‑type drug, it is used primarily to provide an immediate source of carbohydrate energy and to support intravascular volume when infused.

Glucose Paracélsia is indicated for several clinical situations where rapid carbohydrate supplementation or fluid replacement is required.

- Treatment of hypoglycemia in patients unable to take oral glucose. - Intravenous fluid replacement for patients with low intravascular volume. - Component of parenteral nutrition regimens to meet caloric needs. - Support during surgical procedures to maintain blood glucose levels. - Adjunct in emergency care when immediate energy source is needed. - Use in pediatric patients for rapid correction of low blood glucose under medical supervision. - Utilized in critical care settings to assist with hemodynamic stabilization when combined with other electrolytes.

Glucose Paracélsia may be associated with a range of adverse effects, most of which are related to the intravenous administration of a carbohydrate solution.

Common: - Transient hyperglycemia when administered in excess. - Local irritation or pain at the infusion site. - Mild electrolyte shifts, such as slight sodium or potassium changes. - Nausea or vomiting if the solution is infused rapidly. - Headache related to rapid changes in blood glucose concentration.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Volume overload causing pulmonary edema in susceptible patients. - Allergic reactions ranging from urticaria to anaphylaxis. - Hyperosmolar hyperglycemic state in patients with impaired insulin response. - Metabolic acidosis secondary to excessive glucose metabolism.

When prescribing Glucose Paracélsia, clinicians should consider several precautionary measures to minimize risk and ensure appropriate use.

- Assess baseline blood glucose and adjust infusion rate to avoid hyperglycemia. - Evaluate fluid status and cardiac function to prevent volume overload. - Use caution in patients with renal impairment due to altered glucose handling. - Monitor electrolytes, especially sodium and potassium, during and after infusion. - Avoid rapid bolus administration; prefer controlled infusion to reduce osmotic effects. - Consider pregnancy and lactation status; data are limited, so use only if clearly indicated.

Glucose Paracélsia can interact with other intravenous therapies; awareness of potential interactions helps maintain patient safety.

Avoid: - Co‑administration with high‑dose insulin infusions without glucose monitoring, which may precipitate severe hypoglycemia. - Simultaneous infusion of hypertonic saline solutions that could exacerbate hypernatremia.

Use with caution: - Concurrent use with other carbohydrate‑containing fluids; adjust total glucose load to prevent hyperglycemia. - Administration alongside diuretics that affect fluid balance; monitor volume status closely. - Use with vasopressors that may alter peripheral perfusion; observe infusion site for signs of irritation. - Interaction with potassium‑sparing agents may increase serum potassium; check levels regularly.